Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem

Can anyone take the top spot away from Eli Lilly in the anti-obesity area?

CryptoAlerta — análise de criptomoedas e mercado em tempo real